CLASS II Device recall · Reported 10 Feb 2016 · FDA Enforcement Report

The ABX Pentra Cholesterol CP recalled by Horiba Instruments

Horiba Instruments is recalling The ABX Pentra Cholesterol CP, distributed in 29 states. The recall was initiated on 11 Jan 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots
Quantity recalled216

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0738-2016
FDA event ID
73033
Recalling firm
Horiba Instruments, Irvine, CA
Classification
Class II
Status
Terminated
Recall initiated
11 Jan 2016
FDA classified
2 Feb 2016
Reported
10 Feb 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

11 Jan 2016Recall initiated by company
2 Feb 2016Classified by FDA+22 days
10 Feb 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

The ABX PENTRA Cholesterol CP ref. A11A01634 is an in vitro diagnostic assay for quantitative determination of cholesterol in human serum and plasma based on an enzymatic photometric test (Trinders reaction). The assay is composed of a 99 ml mono-reagent cassette. Reagent is a chemical solution with additives.

Where it was distributed

U.S. distribution to the following; CA, NY, AL, OK, MN, MS, MD, TX, KY, WV, MT, IL, FL, VA, WA, MI, KS, NE, PA, OH, ID, OR, AR, AZ, NM, NC, SC, GA, TN No foreign distribution.

AlabamaArkansasArizonaCaliforniaFloridaGeorgiaIdahoIllinoisKansasKentuckyMarylandMichiganMinnesotaMississippiMontanaNorth CarolinaNebraskaNew MexicoNew YorkOhio

Questions about this recall

Is The ABX Pentra Cholesterol CP recalled?

Yes. Horiba Instruments recalled The ABX Pentra Cholesterol CP on 11 Jan 2016. The recall is Class II and its status is Terminated. Recall number Z-0738-2016.

Why was it recalled?

N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.

Which lots are affected?

All Lots

Where was it sold?

U.S. distribution to the following; CA, NY, AL, OK, MN, MS, MD, TX, KY, WV, MT, IL, FL, VA, WA, MI, KS, NE, PA, OH, ID, OR, AR, AZ, NM, NC, SC, GA, TN No foreign distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Horiba Instruments

All 26

Other Test Kits & Diagnostics recalls

All 2,656